NCT05332340 2025-03-07
Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered
Biozeus Biopharmaceutical S.A.
Phase 1 Completed
Clinical Trials
9 trialsNCT04488068 2024-07-29
Transpelvic Magnetic Stimulation to Improve Urogenital Function
VA Office of Research and Development
Phase NA Completed
NCT03343093 2024-04-02
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors
University of Minnesota
Phase NA Completed
NCT03830164 2023-10-17
Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01105130 2021-09-28
L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors
Wake Forest University Health Sciences
Phase 2 Completed
NCT00737893 2021-04-08
ERECT
Johns Hopkins University
Phase 2 Completed
NCT00179517 2019-07-17
Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo
Beth Israel Deaconess Medical Center
Phase 2 Completed
NCT00142506 2017-10-20
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT00106392 2010-11-23
A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy
Astellas Pharma Inc
Phase 4 Completed